CRN review backs creatine safety
A CRN review of 162 clinical studies found no serious adverse events linked to creatine and supports a 10-gram daily adult intake level.
A CRN review of 162 clinical studies found no serious adverse events linked to creatine and supports a 10-gram daily adult intake level.
CRN says preliminary research linking caffeinated products to cardiovascular events overlooks differences in ingredients, consumption and dosage, limiting conclusions about consumer risk.
CRN’s newest members span precision fermentation, ingredient sourcing, supply chain verification and business law.
“Companies join CRN because they want to be well informed, connected to like-minded, best-in-class contacts in our community, and engaged in the issues that matter most to them and to the future of the industry.”
“CRN urges FDA to prioritize addressing these fundamental issues to provide the regulatory certainty necessary to support responsible innovation and consumer access to safe dietary supplements.”
Following tireless advocacy against AB 2030, association pledges continued defense of consumer access and science-based policy in face of unsupported restrictions on weight management and sports nutrition dietary supplements
The exemption removes uncertainty over whether supplement manufacturers would need to change established expiration and shelf-life labeling.
The Dietary Supplement Innovation Act would revise federal rules on when drug-investigated ingredients can be marketed as dietary supplements.
CRN says Consumer Reports’ prenatal vitamin testing requires additional context on voluntary standards and testing methods.
CRN urged regulators and platforms to act against illegal health claims, remove deceptive sellers, and inform consumers to identify legitimate products.
“CRN continues to attract companies that are committed to advancing science, quality, and responsible innovation throughout the dietary supplement supply chain,” said Steve Mister, president and CEO of CRN.
“Women’s health is entering a new era of scientific discovery, creating unprecedented opportunities to improve health and quality of life through evidence-based nutrition,” said Andrea Wong, Ph.D., CRN’s senior vice president and chief science officer.
The conference will explore emerging risks, compliance strategies, and evolving legal and business challenges in the creator economy.
Participants held more than 60 meetings with congressional offices.
CRN’s annual business conference will spotlight innovation, science communication and collaboration across the supplement industry.
CRN’s new “Sergeant Searchlight” initiative aims to spotlight the need for mandatory FDA product listings for dietary supplements and stronger marketplace oversight.